Clinical Trial Update: Atorvastatin Versus Ezetimibe and Fenofibrate as a Lipid-lowering Strategy

View source ↗

Summary

A clinical trial comparing atorvastatin versus ezetimibe plus fenofibrate as lipid-lowering strategies has completed. The study was sponsored by Queen's Univers…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dyslipidemia
• Vascular Disease

Drugs mentioned

• EZETIMIBE (EZETIMIBE)
• FENOFIBRATE (Fenofibrate)
• atorvastatin (atorvastatin)

Snippet

Sponsor: Queen's University | Conditions: Dyslipidemia, Vascular Disease | Status: COMPLETED